Skip to content

❤️ Cardiology

Free study guide · No login required


📄 Downloadable Study Guides

View online or download PDF versions for offline study. The guide and PDFs on this page were checked against the 2025 AHA guidelines, the 2025 ACC/AHA ACS guideline and the current NREMT test plan (November 2026).

🚑 EMT Cardiology Guides ▼
EMT Cardiology Study Guide 2025
CPR/AED, ACS management, shock recognition, bleeding control, NREMT scenarios
🏥 Paramedic Cardiology Guides ▼
Paramedic Cardiology: ACLS & Arrest Management 2025-2026
Cardiac arrest protocols, VF/VT vs Asystole/PEA, STEMI management, arrhythmia treatment, post-ROSC care
Synchronized Cardioversion vs Defibrillation 2025
Sync vs unsync, R-on-T, biphasic vs monophasic, pads, ICDs, drug timing (AHA 2025)
PALS 2025 Essentials: Pediatric Advanced Life Support 2025
Systematic approach, respiratory failure, shock, pediatric arrest, bradycardia and tachycardia algorithms, post-arrest care (AHA 2025)
Paramedic Cardiology: 12-Lead & Pharmacology 2025-2026
12-lead ECG interpretation, STEMI patterns, ACS recognition, dysrhythmias, ACLS medications
12-Lead ECG Interpretation Guide 2025-2026
STEMI patterns, lead placement, axis, intervals, rate calculation, systematic interpretation
Paramedic Cardiology Study Guide (Original) 2025
Comprehensive overview: 12-lead ECG, dysrhythmias, ACLS algorithms, cardiac pharmacology

Source: www.emsnotes.com by Forrest Munden


Cardiology for the Paramedic: 12-Lead, ACS, Dysrhythmias, ACLS & Pharmacology

This is the working cardiology review for paramedic students and practicing medics: how to read a 12-lead under pressure, what actually counts as a STEMI, how to recognize the rhythms you will see on the NREMT and on the street, the current AHA ACLS algorithms, and the cardiac drugs with their doses and contraindications. Every dose, energy setting and criterion below was checked against the current AHA and ACC/AHA source documents listed at the bottom of the page.

On the NREMT. In the current NREMT Paramedic test plan, Cardiology & Resuscitation is 10–14% of the exam, and about 30% of that domain is graphical items built on ECG strips. Clinical Judgment items run through the whole exam. Expect to identify a rhythm, decide whether the patient is stable, and choose the next action.

Section 1: 12-Lead Interpretation

Read every 12-lead the same way, every time. Most misses on a 12-lead are not knowledge gaps. They happen because the medic jumped straight to the ST segments and skipped the rest.

A systematic approach

The step-by-step read (rate, rhythm, P waves, QRS, ST segments, T waves) is covered in Paramedic Cardiology, Section 2. Two habits to add: treat the patient, not the paper, and repeat the 12-lead whenever symptoms change or the first one isn't diagnostic. At 25 mm/sec, one small box is 0.04 sec and one large box is 0.20 sec. The intervals, territories, axis and bundle branch block material below isn't covered elsewhere on the site.

MeasureNormal (adult)What abnormal suggests
PR interval0.12–0.20 sec>0.20 sec is first-degree AV block. A short PR with a delta wave suggests pre-excitation (WPW).
QRS duration<0.12 sec≥0.12 sec is a wide QRS: bundle branch block, ventricular origin, paced rhythm, hyperkalemia, or sodium-channel-blocker toxicity.
QT / QTcRate dependent; use the QTcA prolonged QTc raises torsades risk. The risk climbs as the QTc approaches and passes 500 ms.

Lead groupings and territories

LeadsWallUsual arteryReciprocal leads to check
II, III, aVFInferiorRCA (most often) or circumflexI, aVL
V1–V2SeptalLAD (septal branches)—
V3–V4AnteriorLADInferior leads (sometimes)
I, aVL, V5–V6Lateral (I/aVL = high lateral)Circumflex or LAD diagonalII, III, aVF
V7–V9PosteriorCircumflex or RCAShows up as ST depression in V1–V3
V4R (right-sided)Right ventricleProximal RCAGet right-sided leads on every inferior STEMI

Contiguous means anatomically neighboring leads, such as II/III/aVF, V1–V6 in sequence, or I/aVL. Two contiguous leads is the minimum for STEMI criteria.

Axis basics

Lead ILead aVFAxisCommon causes
PositivePositiveNormal (about −30° to +90°)—
PositiveNegativeLeft axis, if lead II is also mostly negativeLeft anterior fascicular block, inferior MI, LBBB, LVH
NegativePositiveRight axisRVH, acute right-heart strain (PE), left posterior fascicular block, lateral MI, limb lead reversal
NegativeNegativeExtreme (“northwest”)Think ventricular origin (VT), hyperkalemia, or lead misplacement

If lead I is positive and aVF is negative, check lead II. If II is positive, the axis is still normal (between 0° and −30°).

Bundle branch block recognition

Right bundle branch blockLeft bundle branch block
QRS≥0.12 sec≥0.12 sec
V1rSR′ (“rabbit ears”), terminal RDeep, broad QS or rS (mostly negative)
I, aVL, V5–V6Wide, slurred S waveBroad, notched or monophasic R. No septal q waves.
ST/TSecondary T inversion in V1–V3 is expectedST/T discordant to the QRS is expected. That is what makes STEMI hard to see in LBBB (see Sgarbossa below).

Quick trick: look at the terminal part of the QRS in V1. If it points up, think right bundle; if it points down, think left bundle. A QRS of 0.10–0.12 sec with the same morphology is an incomplete block. A new RBBB with left anterior fascicular block (a left axis) in a patient with chest pain should raise concern for a proximal LAD lesion.

Section 2: ACS Recognition

Acute coronary syndrome includes unstable angina, NSTEMI and STEMI. In the field, our job is to find the STEMI fast, recognize the high-risk patient without a STEMI, and get both to the right hospital. The 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS guideline calls for a 12-lead within 10 minutes of first medical contact, and serial 12-leads when the first one isn't diagnostic but the story is.

STEMI criteria (2025 ACC/AHA ACS guideline)

The short version is in Paramedic Cardiology, Section 2. These are the current 2025 values: note that a new LBBB is no longer treated as a STEMI equivalent (see below). New ST elevation at the J point in at least 2 contiguous leads, in the absence of LVH or LBBB:

LeadsThreshold
All leads other than V2–V3≥1 mm
V2–V3, men age ≥40≥2 mm
V2–V3, men age <40≥2.5 mm
V2–V3, women (any age)≥1.5 mm
  • Posterior MI: ST depression in V1–V3, often with tall R waves and upright T waves, is posterior ST elevation seen from the front. Put on V7–V9. The Fourth Universal Definition of MI uses ≥0.5 mm of ST elevation in V7–V9 (≥1 mm in men under 40).
  • Right ventricular MI: with any inferior STEMI, get right-sided leads. The Fourth Universal Definition uses ST elevation in V3R–V4R of ≥0.5 mm (≥1 mm in men under 30). These patients are preload dependent: nitrates can drop the pressure hard, and they often need fluid.

NSTEMI / unstable angina

The ACS guideline describes NSTE-ACS ECG findings as new horizontal or downsloping ST depression ≥0.5 mm in 2 contiguous leads and/or T-wave inversion >1 mm in 2 contiguous leads with a prominent R wave. A normal ECG does not rule out ACS. Treat the story, repeat the 12-lead, and let the hospital sort out troponin.

Reciprocal changes

Reciprocal ST depression on the opposite wall makes a true STEMI much more likely than a mimic.

  • Inferior STEMI (II, III, aVF): look for depression in I and aVL. Subtle depression in aVL can be the earliest clue.
  • High lateral STEMI (I, aVL): look for depression in III and aVF.
  • Posterior MI: depression in V1–V3 is the “reciprocal” view. Confirm with V7–V9.
  • Diffuse ST elevation without reciprocal changes (except aVR/V1), with PR depression, points toward pericarditis.

Hear it talked through: Podcast: STEMI & Reciprocal Changes.

High-risk patterns that don't meet the STEMI table

These are widely taught ECG patterns. They are not part of the ACC/AHA STEMI criteria table, so handle them the way your protocol says: transmit, call medical direction, and choose your destination with that in mind.

  • Hyperacute T waves: broad, tall, symmetric T waves out of proportion to the QRS. Often the earliest sign of occlusion. Repeat the ECG in a few minutes.
  • De Winter pattern: upsloping ST depression at the J point in V1–V6 with tall, symmetric T waves. Associated with proximal LAD occlusion.
  • Wellens pattern: deep symmetric or biphasic T waves in V2–V3 in a pain-free patient. Suggests a critical LAD lesion.
  • Diffuse ST depression with ST elevation in aVR: suggests widespread subendocardial ischemia (left main or multivessel disease, or a non-coronary cause such as severe anemia or tachycardia).

LBBB, paced rhythms and Sgarbossa

The 2025 ACS guideline is explicit: a new or presumed-new LBBB by itself is not diagnostic of acute MI and should not be treated as a STEMI equivalent. Interpret it in the clinical context. To find an occlusion hidden behind a LBBB or ventricular paced rhythm, many systems use these clinical decision tools. They come from the cardiology literature, not from AHA guidance, so follow your local STEMI protocol on how to use them.

Sgarbossa criteria (Sgarbossa et al., NEJM 1996)Points
Concordant ST elevation ≥1 mm in any lead (ST goes the same direction as the QRS)5
Concordant ST depression ≥1 mm in V1, V2 or V33
Excessively discordant ST elevation ≥5 mm (ST elevation in leads with a negative QRS)2

A score of ≥3 is considered specific for acute MI. Modified Sgarbossa (Smith et al., Annals of Emergency Medicine 2012) keeps the first two criteria and replaces the fixed 5 mm rule with a proportion: discordant ST elevation that is ≥25% of the depth of the preceding S wave (ST/S ratio ≤ −0.25) in any lead. Any one modified criterion is considered positive. The proportional rule works better with small complexes and very large voltage.

Go deeper: Podcast: Bundle Branch Blocks, Sgarbossa & STEMI Mimics.

STEMI mimics

MimicWhat gives it away
PericarditisDiffuse concave ST elevation across many territories, PR depression (PR elevation in aVR), no reciprocal depression except aVR/V1, pleuritic or positional pain
Early repolarizationYoung patient, concave ST elevation (mostly V2–V4), notched or slurred J point, stable over serial ECGs
LVHLarge voltages, ST elevation in V1–V3 discordant to deep S waves, lateral “strain” pattern
LBBB / ventricular paced rhythmWide QRS with expected discordant ST/T. Use Sgarbossa or modified Sgarbossa and clinical context.
Brugada patternCoved ST elevation in V1–V2 with T inversion, RBBB-like morphology. Syncope or arrest history matters.
Takotsubo cardiomyopathyLooks like an anterior STEMI, often after severe emotional or physical stress. You can't tell it apart in the field; treat it as STEMI.
HyperkalemiaPeaked T waves, widening QRS, flattened P waves, and sometimes ST elevation in V1–V2. Dialysis or renal history.
LV aneurysmPersistent ST elevation with Q waves from an old anterior MI. An old ECG is gold here.

When in doubt, it is a STEMI until proven otherwise. Transmit, call it early per protocol, and keep repeating ECGs.

Prehospital ACS care (2025 ACC/AHA ACS guideline)

The EMT-level chest pain assessment is in EMT Cardiology, and the general drug doses are in Medication Dosages. These current 2025 points are the ones not stated elsewhere on the site:

  • 12-lead within 10 minutes of first medical contact. Transmit it and activate the cath lab from the field when your system allows.
  • Destination: take EMS-identified STEMI directly to a PCI-capable center. The goal is first medical contact to device ≤90 minutes (≤120 minutes when the transport is longer). Cardiogenic shock and resuscitated arrest with STEMI also belong at a PCI center.
  • Aspirin 162–325 mg chewed, non-enteric-coated, even if the patient already takes daily aspirin.
  • Oxygen only if SpO2 is <90%. Routine oxygen for patients at ≥90% is not recommended.
  • Nitroglycerin 0.3–0.4 mg SL every 5 min, up to 3 doses. Don't give it if SBP is <90 mmHg or ≥30 mmHg below baseline, with suspected RV infarction, or after a phosphodiesterase inhibitor (avanafil within 12 h, sildenafil or vardenafil within 24 h, tadalafil within 48 h).
  • Opioids are only for pain that persists despite anti-ischemic therapy: morphine 2–4 mg IV, repeated every 5–15 min, or fentanyl 25–50 mcg IV (up to 100 mcg). Opioids can delay the effect of oral P2Y12 inhibitors. Avoid NSAIDs other than aspirin.

Section 3: Dysrhythmia Recognition

For every strip, ask how fast it is, whether it's regular, whether there's a P for every QRS, and whether the QRS is narrow or wide. Then decide whether the patient is stable and whether this rhythm is the cause of the problem. The core rhythms are covered elsewhere on the site:

The rhythms and points below aren't covered on those pages.

RhythmRecognitionField pearl
Mobitz II and third-degree with a wide escapeInfranodal block; the QRS is usually wideAtropine is unlikely to work. Pads on, and don't delay pacing. A narrow junctional escape in third-degree block may still respond to atropine.
Idioventricular / accelerated idioventricular (AIVR)Wide QRS, no P waves, rate 20–40 (accelerated 40–100)Often a perfusing escape or reperfusion rhythm. Don't suppress it with an antiarrhythmic.
Multifocal atrial tachycardiaIrregular, ≥3 different P-wave shapes, rate >100Usually driven by COPD or hypoxia. Treat the lungs, not the rhythm. Don't cardiovert.
WPW / pre-excited AFIn sinus rhythm: short PR, delta wave. In AF: irregular, wide, very fast, varying QRS width.Avoid AV-nodal blockers (adenosine, diltiazem, verapamil, β-blockers, digoxin) and IV amiodarone. They can speed conduction down the accessory pathway.
Polymorphic VT vs torsadesWide, chaotic QRS that changes shape. Torsades twists around the baseline in a setting of long QT.Sustained polymorphic VT is unstable: give a defibrillation (unsynchronized) dose. Magnesium is for torsades with a long QT, not for polymorphic VT with a normal QT.
PEA: narrow vs wideAn organized rhythm without a palpable pulseNarrow and fast points toward mechanical causes (tamponade, tension pneumothorax, hypovolemia, PE). Wide and slow points toward metabolic or toxic causes (hyperkalemia, sodium-channel blockers).

Section 4: Current AHA ACLS Algorithms (2025)

These are summarized from the 2025 AHA Guidelines for CPR and ECC and the 2025 algorithm cards on cpr.heart.org, including the February 2026 change notice (ventilation with an advanced airway is 1 breath every 6 seconds; bradycardia assessment now lists establishing vascular access). Run them on the ACLS Simulator.

Adult cardiac arrest

The shockable and non-shockable pathways are covered in Sync vs Defib, Sections 3 and 7: shock energy, epinephrine after the initial shocks fail versus as soon as feasible, amiodarone or lidocaine after the third shock, and what's not routinely recommended. The H's and T's are in Paramedic Cardiology, Section 4. Current 2025 points not stated on those pages:

  • CPR quality: push at least 2 inches (5 cm) at 100–120/min with full recoil. With an advanced airway, give 1 breath every 6 seconds (10/min) with continuous compressions.
  • ETCO2: aim for at least 10 mmHg, ideally ≥20 mmHg, as a gauge of CPR quality (practice with the Capnography Quiz). Use waveform capnography to confirm and monitor ETT placement.
  • Amiodarone and lidocaine are equal options; the AHA does not prefer one over the other.
  • Termination: ETCO2 <10 mmHg after 20 minutes of CPR in an intubated patient can be one part of a multimodal decision. Never use it alone. Follow your local termination-of-resuscitation protocol.

Adult bradycardia with a pulse

  1. A heart rate typically <50 when the bradyarrhythmia is the problem. Support the airway and breathing, give oxygen if hypoxemic, put on the monitor, establish vascular access, and get a 12-lead.
  2. Check for cardiopulmonary compromise: hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, or acute heart failure. If none, observe and treat the cause.
  3. Atropine 1 mg IV, repeated every 3–5 min, to a maximum of 3 mg.
  4. If atropine is ineffective, use transcutaneous pacing and/or a dopamine infusion of 5–20 mcg/kg/min or an epinephrine infusion of 2–10 mcg/min, titrated to response.
  5. Consider expert consultation and transvenous pacing (the 2025 guidelines call transvenous pacing reasonable for persistent unstable bradycardia refractory to medical therapy).

Look for the causes: ischemia or infarction, drugs (CCB, β-blocker, digoxin), hypoxia, and hyperkalemia.

Adult tachyarrhythmia with a pulse

  1. A heart rate typically ≥150 when the tachyarrhythmia is the cause. Support the ABCs, give oxygen if hypoxemic, put on the monitor, get a 12-lead, and identify and treat the cause. Ask whether the rhythm is causing the instability or responding to something else, such as sepsis, hypovolemia or pain.
  2. Unstable (hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, acute heart failure): synchronized cardioversion, with sedation when it is feasible. If the rhythm is a regular narrow-complex tachycardia, adenosine may be considered while you prepare to cardiovert, but don't let it delay the shock.
  3. Stable, wide QRS (≥0.12 sec): adenosine only if the rhythm is regular and monomorphic. Consider procainamide, amiodarone or sotalol, and seek expert consultation. Verapamil and diltiazem are harmful in wide-complex tachycardia.
  4. Stable, narrow QRS: vagal maneuvers (including the modified Valsalva), then adenosine if regular. Then a β-blocker or calcium channel blocker, and expert consultation.

Cardioversion energy (AHA 2025 Electrical Cardioversion Algorithm): narrow regular tachycardia 100 J, monomorphic VT 100 J, AF 200 J (at least 200 J), flutter 200 J; increase if the first shock fails, per your device. Polymorphic VT is never synchronized. Timing, pads and sedation are covered in Sync vs Defib.

  • AF/flutter rate control (stable): an IV β-blocker or non-dihydropyridine calcium channel blocker (diltiazem, verapamil). Avoid these in decompensated heart failure or significant LV dysfunction. In pre-excited AF (WPW), avoid AV-nodal blockers and IV amiodarone.

Post-cardiac arrest care (ROSC)

Paramedic Cardiology, Section 4 covers post-arrest care in outline. The 2025 targets in detail:

  • Airway: place or confirm an advanced airway as needed, and confirm placement with waveform capnography.
  • Oxygen: give 100% FiO2 until SpO2 can be measured reliably, then titrate to an SpO2 of 90–98% (PaO2 60–105 mmHg). Be aware that pulse oximetry can overestimate saturation in patients with darker skin.
  • Ventilation: PCO2 35–45 mmHg unless there is severe acidemia. Don’t hyperventilate.
  • Hemodynamics: keep MAP ≥65 mmHg with fluids and/or vasopressors.
  • 12-lead ECG early. Consider emergency coronary angiography for persistent ST elevation, cardiogenic shock, recurrent or refractory ventricular arrhythmias, or severe ischemia. Transport to a PCI-capable center per protocol.
  • Glucose: avoid hypoglycemia (<70 mg/dL) and hyperglycemia (>180 mg/dL).
  • Temperature: if the patient is not following commands, start a deliberate temperature-control strategy with a goal of 32–37.5 °C, kept for at least 36 hours. Prevent fever.

Section 5: Cardiac Pharmacology

Full adult ACLS drug doses (epinephrine, amiodarone, lidocaine, atropine, adenosine, dopamine, magnesium, procainamide, diltiazem, verapamil and more) are in Medication Dosages, Section 2. Pediatric doses are in PALS Essentials. The ACS drugs (aspirin, oxygen, nitroglycerin, morphine, fentanyl) are covered in Section 2, and the post-ROSC oxygen target is in Section 4. This table adds the cardiac-specific details and current 2025 values that aren't on those pages:

DrugDetail to know (AHA 2025)
Adenosine6 mg rapid IV push, then 12 mg (the 2025 algorithm lists two doses). Consider about 1 mg via a central line or in heart transplant patients. Contraindicated in asthma or bronchospasm. Never use it for irregular, polymorphic or unstable wide-complex tachycardia.
AmiodaroneWith a pulse: 150 mg over 10 min, repeated as needed, then a maintenance infusion of 1 mg/min for the first 6 hours. Avoid it in torsades or long QT and in pre-excited AF.
Procainamide20–50 mg/min. Stop when the arrhythmia is suppressed, hypotension develops, the QRS widens by >50%, or you reach 17 mg/kg. Maintenance 1–4 mg/min. Avoid with a prolonged QT or heart failure. Not used in cardiac arrest.
Atropine1 mg every 3–5 min, maximum 3 mg. Unlikely to work after a heart transplant. Not part of the arrest algorithm.

Guideline version verified

Content checked on November 4, 2026 against:

  • The 2025 AHA Guidelines for CPR and ECC: Part 9 (Adult ALS) and Part 11 (Post-Cardiac Arrest Care).
  • The 2025 AHA adult algorithms: cardiac arrest, bradycardia, tachyarrhythmia and post-cardiac arrest care.
  • The AHA change notices dated February 6, 2026 and August 11, 2026.
  • The 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Acute Coronary Syndromes.
  • The current NREMT Paramedic test plan.

AHA lists no newer focused update to adult ALS than the 2025 guidelines. The downloadable PDFs above were updated to the same 2025 values in November 2026.

Sources

Follow your local protocols and medical direction. This guide is for education and NREMT preparation. Doses, energies, destination criteria and scope of practice vary by agency, state and device. Your local protocols, your medical director and the manufacturer’s instructions for your equipment always come first.
Share on Facebook Share on X